Entheon Biomedical Announces Investment and Business Arrangement with Heading Health LLC Post published:January 4, 2021 Post category:Press Release
Nova Mentis Appoints Dr. Kyle Ambert to Scientific Advisory Board Post published:January 4, 2021 Post category:Press Release
Psychedelic Bulletin: First Psychedelic ETF Set to Launch; Beckley Psytech Raises £14m; Reviewing the Psychedelic Renaissance in 2020 Post published:January 2, 2021 Post category:Psychedelic Bulletin
Red Light Holland Engages Graham Pechenik, Respected Patent and IP Lawyer and Editor-at-Large of Psilocybin Alpha, as Senior Advisor to Advisory Board Post published:December 31, 2020 Post category:Press Release
Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study Post published:December 31, 2020 Post category:Press Release
Mind Cure Announces Retail Roll Out of Nootropics Lineup Across North America with Body Energy Club Post published:December 31, 2020 Post category:Press Release
BetterPlant Subsidiary NeonMind Closes Oversubscribed Initial Public Offering and Exercise in Full of the Agent’s Over-Allotment Option Post published:December 31, 2020 Post category:Press Release
Legal Psychedelic Therapy Comes to Alberta With Ground-Breaking Health Canada Decision Post published:December 30, 2020 Post category:Press Release
The Psychedelic Renaissance in 2020 Post published:December 30, 2020 Post category:Analysis/Editorial